Helicobacter Pylori Infection: A Review of Current Scientific Research on the Efficacy Or Potential of Herbal Medicine for the Treatment of H. Pylori Infection of the Gastric Mucosa (Undergrad Copy) - Australian Journal of Medical Herbalism
Introduction Helicobacter pylori is a common bacterium that infects the stomachs of approximately 50% of the world population (Go 2002). Australian physicians Warren and Marshall discovered the unidentified bacteria in the early 1980s in the gastric mucosa and duodenum of patients suffering from peptic ulceration (Gaby 2001). It is now accepted that Helicobacter pylori infection is a precursor to chronic gastritis, peptic and duodenal ulceration (Gaby 2001). Where gastric inflammation persists for decades, atrophic gastritis can evolve into adenocarcinoma or increase the person's risk of developing mucosa associated lymphoid tissue (MALT) lymphomas (Evans 2000, Guruge 1998). From 30-90% of gastric carcinomas are attributable to Helicobacter pylori infection (Guruge 1998). In countries such as Japan where the incidence of gastric cancer is high, the infection rate of Helicobacter pylori has also been found to be high (Go 2002). Helicobacter pylori infection is hypothesised to play a role in cardiovascular disease in some people however clear evidence is yet to be uncovered (Gasbarrini 1999, Martinez-Torres 2002).